KOTAI Biotechnologies
Minoh
About KOTAI Biotechnologies
KOTAI Biotechnologies is a research base that represents immunological bioinformatics and information structural analysis. They conduct research and development with institutions and universities, as well as with business companies such as pharmaceutical companies. They provide for the development of diagnostic and treatment methods. From a routine blood sample, platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution. Repertoire Builder can group receptors according to their target epitopes using sequence and structural features from B or T cell receptor models, revealing the functional landscape of a donor and quantifying differences between donors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.6M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2019)
- Website: kotai-bio.comjp
- Phone: +81 06-6170-5267
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kotai-biotechnologies-200339 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.